ftInvstr
TAKE · Healthcare ₹13.82 +4.94% Mkt Cap ₹202 Cr
← Search another stock

TAKE

Healthcare Biotechnology
★ Watchlist ⧉ Add to bucket
₹13.82
+4.94% today · 30d -38.58%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for TAKE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹30 Cr
NET PROFIT
₹1 Cr
OPM
3.35%
+1791.16pp YoY
EPS
₹0.07
PE 34.55
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.0% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
TAKE34.5519.0
BIOCON154.516.88
ANTHEM91.3531.1
ONESOURCE—5.79
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
53
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation FAIR 40
Growth DECLINING 24
Profitability DECENT 55
Technicals BEARISH 18
Risk LOW 90
Key Stats
TTM PE
34.55
P/B
7.04
52W HIGH
₹50.14
OFF HIGH
-72.44%
MKT CAP
₹202 Cr
◉ Active Signals
MACDBearish-0.6912
RSI(14)Bullish19.98
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold TAKE and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.